An experimental model for pharmacokinetic analysis in renal failure

Area of Science:

• Pharmacology
• Nephrology
• Veterinary Medicine

Background:

• Drug pharmacokinetics are significantly influenced by renal function.
• Understanding these changes is crucial for effective drug therapy in patients with kidney disease.
• A reliable animal model is needed to study these effects.

Purpose of the Study:

• To develop and validate a canine model of chronic kidney disease (CKD).
• To evaluate the impact of varying degrees of renal dysfunction on drug pharmacokinetics.
• To assess changes in oxytetracycline (OTC) pharmacokinetics following induced renal failure.

Main Methods:

• A canine model of renal failure was created by surgically impairing renal function.
• Renal dysfunction severity was quantified using the percentage of normal glomerular filtration rate (% NGFR), estimated via 125I-iothalamate clearance.
• Oxytetracycline (OTC) pharmacokinetics were compared before and after renal impairment in dogs with varying degrees of CKD (severe, moderate, mild).

Main Results:

• The induced renal failure model effectively created distinct classes of renal dysfunction.
• Significant reductions in OTC pharmacokinetic parameters for elimination and distribution were observed with increasing severity of renal failure.
• Oral absorption of OTC was not significantly affected by the induced renal failure.

Conclusions:

• The developed canine model accurately reflects varying degrees of renal failure.
• Renal failure significantly alters the elimination and distribution of drugs like OTC.
• Drug absorption via oral administration remains largely unaffected in this model of renal failure.